Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 family 2 subfamily E member 1 (CYP2E1) is a membrane-bound monooxygenase enzyme found primarily in the liver, where it metabolizes small molecule substrates including ethanol, anesthetics, and chemical carcinogens. It plays crucial roles in drug metabolism, detoxification, and the synthesis of endogenous molecules; however, it can also generate toxic or carcinogenic metabolites. Its expression is highly inducible by ethanol, fasting, diabetes, and other states, and its activity is central to both normal physiology (e.g., gluconeogenesis and fatty acid metabolism) and pathophysiological conditions such as alcoholic liver disease and cancer risk. CYP2E1's ability to metabolize many low molecular weight compounds makes it a key therapeutic target and a source of safety concern when the enzyme is induced or dysfunctional.
Oxidation and hydroxylation of substrates. Bioactivation of procarcinogens. Generation of toxic metabolites. Catalysis of monooxygenase reactions: RH + O₂ + 2H⁺ + 2e⁻ → ROH + H₂O
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 family 2 subfamily E member 1 (CYP2E1).